Remote prescribing is the practice of healthcare professionals issuing prescriptions without face-to-face consultation. In UK Primary Care Networks, this typically occurs via telephone, video calls, online platforms or apps. It enables clinicians to prescribe medications after assessing patients virtually, following GMC guidelines to ensure safety and appropriate care.
Yes, remote prescribing is both legal and safe when conducted properly. The General Medical Council (GMC) provides comprehensive guidance for healthcare professionals. Prescribers must ensure they have adequate information about the patient's health, can make appropriate clinical assessments, and communicate effectively. However, certain medications with higher risks or those requiring physical examination may not be suitable for remote prescribing.
Remote prescribing is generally suitable for stable, chronic conditions where the patient is known to the practice, such as hypertension, hypothyroidism, or diabetes maintenance. It's also appropriate for minor, well-recognised conditions like UTIs, minor skin conditions, or hay fever. Repeat prescriptions for ongoing medications can often be handled remotely. Conditions requiring physical examination, high-risk medications, or complex new presentations typically require in-person assessment.
The COVID-19 pandemic dramatically accelerated the adoption of remote prescribing across UK Primary Care Networks. Out of necessity, practices rapidly implemented digital systems to maintain patient care while minimising infection risk. The NHS introduced temporary regulatory adjustments to facilitate this shift. Post-pandemic, many PCNs have maintained hybrid models, combining remote prescribing with traditional care. This transformation has improved access for many patients, particularly those with mobility issues or in rural areas.
The NHS utilises several technology systems to facilitate safe remote prescribing. These include the Electronic Prescription Service (EPS), which allows prescriptions to be sent electronically to pharmacies; NHS App, enabling patients to request repeat prescriptions; EMIS Web and SystmOne for clinical record-keeping and prescribing; video consultation platforms like AccuRx and Attend Anywhere; and the NHS Spine, which supports secure information sharing between healthcare settings.
{
"@context": "https://schema.org",
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "What does Remote Prescribing mean?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Remote prescribing is the practice of healthcare professionals issuing prescriptions without face-to-face consultation. In UK Primary Care Networks, this typically occurs via telephone, video calls, online platforms or apps. It enables clinicians to prescribe medications after assessing patients virtually, following GMC guidelines to ensure safety and appropriate care."
}
},
{
"@type": "Question",
"name": "Is remote prescribing safe and legal in the UK?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Yes, remote prescribing is both legal and safe when conducted properly. The General Medical Council (GMC) provides comprehensive guidance for healthcare professionals. Prescribers must ensure they have adequate information about the patient's health, can make appropriate clinical assessments, and communicate effectively. However, certain medications with higher risks or those requiring physical examination may not be suitable for remote prescribing."
}
},
{
"@type": "Question",
"name": "What types of conditions are suitable for remote prescribing?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Remote prescribing is generally suitable for stable, chronic conditions where the patient is known to the practice, such as hypertension, hypothyroidism, or diabetes maintenance. It's also appropriate for minor, well-recognised conditions like UTIs, minor skin conditions, or hay fever. Repeat prescriptions for ongoing medications can often be handled remotely. Conditions requiring physical examination, high-risk medications, or complex new presentations typically require in-person assessment."
}
},
{
"@type": "Question",
"name": "How has the COVID-19 pandemic affected remote prescribing in Primary Care Networks?",
"acceptedAnswer": {
"@type": "Answer",
"text": "The COVID-19 pandemic dramatically accelerated the adoption of remote prescribing across UK Primary Care Networks. Out of necessity, practices rapidly implemented digital systems to maintain patient care while minimising infection risk. The NHS introduced temporary regulatory adjustments to facilitate this shift. Post-pandemic, many PCNs have maintained hybrid models, combining remote prescribing with traditional care. This transformation has improved access for many patients, particularly those with mobility issues or in rural areas."
}
},
{
"@type": "Question",
"name": "What technology systems support remote prescribing in the NHS?",
"acceptedAnswer": {
"@type": "Answer",
"text": "The NHS utilises several technology systems to facilitate safe remote prescribing. These include the Electronic Prescription Service (EPS), which allows prescriptions to be sent electronically to pharmacies; NHS App, enabling patients to request repeat prescriptions; EMIS Web and SystmOne for clinical record-keeping and prescribing; video consultation platforms like AccuRx and Attend Anywhere; and the NHS Spine, which supports secure information sharing between healthcare settings."
}
}
]
}